Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)

SHA:688319 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	11,579	10,294	4,303	6,417	5,621	14,513
Market Cap Growth	151.54%	139.25%	-32.95%	14.17%	-61.27%	-
Enterprise Value	11,767	10,482	4,422	6,267	5,420	14,115
Last Close Price	28.54	25.36	10.60	15.74	13.81	35.67
PE Ratio	520.83	463.05	207.29	365.54	211.50	134.42
Forward PE	196.83	131.33	98.61	60.77	38.44	59.68
PS Ratio	16.44	14.62	7.31	12.94	10.27	29.79
PB Ratio	11.96	10.63	4.61	6.90	6.30	17.18
P/TBV Ratio	12.28	10.92	4.74	7.13	6.51	17.47
P/OCF Ratio	-	-	-	145.85	-	363.16
EV/Sales Ratio	16.71	14.89	7.51	12.63	9.90	28.97
EV/EBITDA Ratio	200.08	178.24	89.21	204.71	135.49	120.71
EV/EBIT Ratio	-	339.71	204.54	1787.91	368.70	150.33
Debt / Equity Ratio	0.41	0.41	0.39	0.26	0.15	0.05
Debt / EBITDA Ratio	6.75	6.75	6.79	6.93	3.35	0.33
Net Debt / Equity Ratio	0.19	0.19	0.13	-0.13	-0.25	-0.49
Net Debt / EBITDA Ratio	3.05	3.05	2.42	-4.07	-5.63	-3.56
Net Debt / FCF Ratio	-	-	-0.55	0.99	1.00	13.99
Asset Turnover	-	-	0.34	0.32	0.41	0.53
Inventory Turnover	-	-	0.38	0.49	0.56	0.47
Quick Ratio	-	-	1.37	1.80	1.63	2.34
Current Ratio	-	-	1.53	1.96	1.78	2.56
Return on Equity (ROE)	2.34%	2.34%	1.69%	1.26%	3.06%	17.68%
Return on Assets (ROA)	-	-	0.79%	0.14%	0.68%	6.33%
Return on Invested Capital (ROIC)	1.87%	1.95%	1.64%	0.35%	1.63%	26.12%
Return on Capital Employed (ROCE)	-	-	1.80%	0.30%	1.50%	10.80%
Earnings Yield	0.19%	0.22%	0.48%	0.27%	0.47%	0.74%
FCF Yield	-	-	-5.04%	-1.96%	-4.01%	-0.21%
Dividend Yield	-	-	-	0.24%	-	-
Payout Ratio	-	-	142.97%	34.11%	16.00%	0.95%
Buyback Yield / Dilution	0.46%	-0.07%	0.01%	-0.07%	-5.22%	-5.61%
Total Shareholder Return	0.46%	-0.07%	0.01%	0.17%	-5.22%	-5.61%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.